Antihypertensive Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Antihypertensive drugs are used to treat hypertension and prevent high blood pressure complications. Hypertension is a medical disorder characterised by persistently high blood pressure in the arteries. Heart failure, ischemic heart disease, stroke, and death are all associated with high blood pressure. Renal impairment, visual impairment, and retinal haemorrhage are all complications of hypertension. Patients use prescribed medication once a day in a low dose. The side effects of these medicines are minor. Various class of drugs are used in management of different kind f hypertensions common category of drugs used are, B- blockers, ACE- inhibitors, diuretics etc.

MARKET SCOPE

The "Global Antihypertensive Drugs Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antihypertensive drugs market with detailed market segmentation by therapeutics and distribution channel. The report provides key statistics on the market status of the leading antihypertensive drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on therapeutics the market is segmented as, diuretics, angiotensin receptor blockers (ARBS), angiotensin converting enzyme (ACE) inhibitors, beta blockers, alpha blockers, calcium channel blockers, renin inhibitors and vasodilators.
  
•   Based on distribution channel the market is segmented as, E-commerce, hospital pharmacies and retail pharmacies.
  

MARKET DYNAMICS
Drivers:

•   Growing prevalence of hypertension and other cardiovascular diseases across the globe.
  
•   Increasing geriatric population along with presence of risk factors such as, obesity, stress, unhealthy lifestyles expected to fuel the market growth.
  
•   Extensive R&D efforts for development of novel therapies for management of hypertension.
  
•   Rising awareness among people about effective management of hypertension.
  

Restraints:

•   However, the expiration of patents is expected to restrain market growth during the forecast period.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antihypertensive drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antihypertensive drugs market in these regions.

IMPACT OF COVID-19 ON ANTIHYPERTENSIVE DRUGS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In this tough time the demand for hypertensive and other cardiovascular agents declined a bit but the sales of such agents is going on through OTC and E-commerce as patients cannot go to clinics often for their checkups. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Antihypertensive Drugs Market Report Analysis

Antihypertensive Drugs Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Pfizer Inc
• Novartis AG
• Boehringer Ingelheim International GmbH
• Glenmark
• Johnson and Johnson Services, Inc.
• AstraZeneca
• FDC Ltd
• Takeda Pharmaceutical Company Limited
• Bayer AG

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Therapeutics

• Diuretics
• Angiotensin Receptor Blockers Beta Blockers
• Alpha Blockers
• Calcium Channel Blockers
• Renin Inhibitors
• Vasodilators

By Distribution Channel

• E-Commerce
• Hospital Pharmacies
• Retail Pharmacies

MARKET PLAYERS

The report covers key developments in the antihypertensive drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from antihypertensive drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for antihypertensive drugs in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antihypertensive drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Pfizer Inc
  
•   Novartis AG
  
•   Boehringer Ingelheim International GmbH
  
•   Glenmark
  
•   Johnson and Johnson Services, Inc.
  
•   AstraZeneca
  
•   FDC Ltd
  
•   Takeda Pharmaceutical Company Limited
  
•   Bayer AG
  
•   Merck Sharp and Dohme Corp
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Antihypertensive Drugs Market Report Scope